Integrated Diagnostics PLC on Thursday said profit nearly doubled during 2024, and that it expects to see ‘further recovery in margins’ throughout 2025.
Integrated is a Cairo, Egypt-based provider of clinical pathology and radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia and Sudan.
The company said pretax profit rose 95% to EGP1.44 billion, about £21.3 million, in 2024, up from EGP737.4 million in 2023.
The firm’s revenue also increased by 39% to EGP5.71 billion in 2024, up from EGP4.12 billion in 2023. This was as a result of the company experiencing rising test and patient volumes, performing 39.2 million tests and serving around 9 million patients across its five markets.
According to Integrated, as inflation normalises across its markets, it expects to see recoveries in its margins, building upon cost optimisation and maximising artificial intelligence tools across the business.
Integrated shares rose 7.4% to $0.35 in London on Thursday afternoon.
Copyright 2025 Alliance News Ltd. All Rights Reserved.